May 27, 2021 Study Finds Adjuvant Immunotherapy of Benefit to Patients With Stage IIB/C Melanoma The ASCO Post
April 17, 2023 Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma The ASCO Post
June 23, 2023 SWOG S1512 Trial: Pembrolizumab Achieves High Response Rates in Rare Type of Melanoma The ASCO Post
April 30, 2025 AACR 2025: Topical BRAF Inhibitor Under Study for Managing Acneiform Rash The ASCO Post
May 23, 2025 In Case You Missed It: Additional Abstracts of Interest in Cancer Research The ASCO Post
April 29, 2025 AACR 2025: Pretrained AI Models Could Help Accurately Diagnose Nonmelanoma Skin Cancers in Resource-Limited Settings The ASCO Post
April 26, 2024 New Social Media Trend Involving Freckle Tattoos May Conceal Early Signs of Skin Cancer Conexiant
April 29, 2024 Exposed to Agent Orange at US Bases, Veterans Face Cancer Without VA Compensation KFF Health News